(Q112052324)

1

0 references

Annika Schundner

2

0 references

Dorota Kmiec

3

0 references

Caterina Prelli Bozzo

4

0 references

Fabian Zech

5

0 references

Lennart Koepke

6

0 references

Alexander Graf

7

0 references

Stefan Krebs

8

0 references

Helmut Blum

9

0 references

Manfred Frick

10

0 references

Konstantin M. J. Sparrer

11

0 references

Frank Kirchhoff

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

12

0 references

publication date

11 May 2022

0 references

published in

Journal of Virology

0 references

cites work

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

A pneumonia outbreak associated with a new coronavirus of probable bat origin

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Detection of a SARS-CoV-2 variant of concern in South Africa

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Syncytia formation by SARS-CoV-2 infected cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Cellular host factors for SARS-CoV-2 infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Opposing activities of IFITM proteins in SARS-CoV-2 infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 variants, spike mutations and immune escape

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1).

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The Sequence Alignment/Map format and SAMtools

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Interferon-induced transmembrane protein 3 is a type II transmembrane protein

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The broad-spectrum antiviral functions of IFIT and IFITM proteins

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM proteins restrict viral membrane hemifusion

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells.

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

A Novel Coronavirus from Patients with Pneumonia in China, 2019

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Detection of SARS-CoV-2 in human breastmilk

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Investigating the mutational landscape of the SARS-CoV-2 Omicron variant via ab initio quantum mechanical modeling

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Receptor Binding and Escape From Beta Antibody Responses Drive Omicron-B.1.1.529 Evolution

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Advancing lung organoids for COVID-19 research

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

SARS-CoV-2 Delta variant infects ACE2 primary human bronchial epithelial cells more efficiently than other variants

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B.1.1.7) variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

S glycoprotein diversity of the Omicron variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Locally Altering Mechanical Properties of Cell Membranes

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance

17 May 2022

1 reference

https://api.crossref.org/works/10.1128/jvi.00594-22